Dandan Luo, PhD

Sr. Principal Scientist II Pmetrics
Johnson & Johnson

Poster(s):

• (M-020) Assessment of Drug-Drug Interaction Effect of Gastric Acid Reducing Agents on Lazertinib Exposure in EGFR-Mutated Non-Small Cell Lung Cancer
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT